📋 Indications & Clinical Dosage
*Depressive illness:*
Adult: 20 mg once daily, increased in steps of 20 mg daily if required, dose to be increased at intervals of 3-4 weeks; max. 40 mg per day.
Elderly: Tab 10-20 mg once daily; max. 20 mg per day.
*Panic disorder:*
Adult: Initially 10 mg daily, increased in steps of 10 mg daily if required, dose to be increased gradually; usual dose 20-30 mg daily; max. 40 mg per day.
Elderly: Initially 10 mg daily, increased in steps of 10 mg daily if required, dose to be increased gradually; max. 20 mg per day.
⛔ Contraindications
QT-interval prolongation, unstable epilepsy, within 2 weeks of stopping moclobemide
⚠️ Precautions & Warnings
Hepatic or severe renal impairment (reduced dose), diabetes, susceptibility to QT-interval prolongation, epilepsy, ECT, mania, risk of bleeding, narrow-angle glaucoma, or history of glaucoma. Monitor for suicidal ideation. Dose increases may be detrimental in patients who develop akathisia. Withdraw gradually.
🔄 Drug Interactions
MAOIs, lithium, tryptophan, pimozide, other neuroleptics, St. Johns Wort, other SSRIs, SNRIs, 5HT1 agonists, triptans, other serotonergic drugs.
⚠️ Adverse Reactions / Side Effects
Aggression, abnormal dreams, taste disturbance, amnesia, bradycardia, confusion, euphoria, haemorrhage, hepatitis, hypokalaemia, impaired concentration, increased salivation, malaise, micturition disorders, migraine, mydriasis, oedema, palpitation, paradoxical increased anxiety during initial treatment of panic disorder (reduce dose), paraesthesia, polyuria, postural hypotension, pruritus, QT-interval prolongation, rhinitis, tachycardia, tinnitus, yawning
🤰 Pregnancy & Lactation Safety
Pregnancy Risk:
Avoid unless potential benefit outweighs risk
Lactation / Breastfeeding:
Contraindicated, avoid
📚 Official Regulatory & Clinical References
- Drug Regulatory Authority of Pakistan (DRAP): Drug Registration, S.R.O. Price Gazettes & National Essential Medicines List (NEML).
- World Health Organization (WHO): Collaborating Centre for Drug Statistics Methodology (ATC/DDD Index).
- Formulary Standards: British National Formulary (BNF) & Pakistan National Formulary (PNF) guidelines.